Identification of two new mutations in congenital erythropoietic porphyria

Eur J Hum Genet. 1995;3(2):102-7. doi: 10.1159/000472283.

Abstract

Congenital erythropoietic porphyria (CEP) or Günther's disease is an inborn error of heme biosynthesis transmitted as an autosomal recessive trait and characterized by a profound deficiency of uroporphyrinogen III synthase (UROIIIS) activity. Six missense mutations in the UROIIIS gene, a deletion and an insertion have already been described in CEP. This work brings further evidence for the heterogeneity in the genetic defect found in CEP. Two new mutations are described, a point mutation (V99A) and a frame-shift mutation (633insA) in the same patient who had a mild to moderate form of Günther's disease. The mutation (V99A) had a detectable residual activity when expressed in Escherichia coli while the insertion (633insA), which introduced a premature stop, had no activity. In the patients studied in our laboratory, the mutation C73R, associated with a severe phenotype, remains the most frequently seen.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Cloning, Molecular
  • Codon, Terminator
  • DNA, Complementary
  • Erythrocytes / metabolism
  • Escherichia coli / genetics
  • Escherichia coli / metabolism
  • Frameshift Mutation*
  • Humans
  • Molecular Sequence Data
  • Phenotype
  • Point Mutation*
  • Porphyria, Erythropoietic / genetics*
  • Porphyrins / metabolism
  • Porphyrins / urine
  • Recombinant Fusion Proteins / metabolism
  • Restriction Mapping
  • Uroporphyrinogen III Synthetase / genetics*
  • Uroporphyrinogen III Synthetase / metabolism

Substances

  • Codon, Terminator
  • DNA, Complementary
  • Porphyrins
  • Recombinant Fusion Proteins
  • Uroporphyrinogen III Synthetase